| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Charles River Laboratories International, Inc. (CRL) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 164 sells. CRL is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 210.7K | $34.31M | - | |
| COO | 65.9K | $10.74M | - | |
| VP | 29.2K | $4.75M | - | |
| VP | 27.4K | $4.46M | - | |
| CFO | 17.3K | $2.82M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Feb 13, 2020 | Barbo William D66 | Corporate Executive VP &CCO | Sell | 6,901 | $172.11 | $1,187,698.68 | -26.7% | |
| Feb 13, 2020 | Girshick Birgit65 | Corporate Executive VP | Sell | 900 | $172.05 | $154,845.00 | -3.7% | |
| Feb 13, 2020 | Smith David Ross63 | Corporate Executive VP &CFO | Sell | 4,500 | $170.29 | $766,318.50 | -17.0% | |
| Dec 9, 2019 | Girshick Birgit65 | Corporate Executive VP | Sell | 1,051 | $145.55 | $152,971.70 | -0.4% | |
| Dec 9, 2019 | Girshick Birgit65 | Corporate Executive VP | Sell | 2,874 | $144.93 | $416,516.02 | -0.5% | |
| Dec 9, 2019 | Girshick Birgit65 | Corporate Executive VP | Sell | 2,420 | $144.21 | $348,993.29 | -0.4% | |
| Dec 9, 2019 | Johst David P | Corporate Executive VP | Sale+OE | 24,660 | $144.21 | $3,556,341.22 | -0.4% | |
| Nov 13, 2019 | Girshick Birgit65 | Corporate Executive VP | Sell | 1,499 | $137.23 | $205,711.82 | -0.5% | |
| Nov 13, 2019 | Girshick Birgit65 | Corporate Executive VP | Sale+OE | 8,105 | $137.04 | $1,110,717.33 | -1.0% | |
| Aug 12, 2019 | Smith David Ross63 | Corporate Executive VP &CFO | Sale+OE | 1,249 | $130.36 | $162,821.40 | -0.3% |